Calcium, Phosphate, Renal Impairment and Coronary Artery Disease in the Cardio-renal Syndrome, The CAPRICORN-CRS Study

This study has been withdrawn prior to enrollment.
(No patients enrolled.)
Sponsor:
Collaborator:
Genzyme, a Sanofi Company
Information provided by:
Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00853541
First received: February 26, 2009
Last updated: July 19, 2011
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: October 2011
  Estimated Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)